Phase II study of bevacizumab plus irinotecan on the treatment of relapsed resistant small cell lung cancer

Dimitrios T. Trafalis, Constantinos Alifieris, George P. Stathopoulos, Nikolaos Sitaras

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of bevacizumab plus irinotecan on the treatment of relapsed resistant small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds